GILD Filing
4Filing Date: Jun 16, 2026
GILEAD SCIENCES, INC. (GILD) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001310204-26-000020open_in_new
Total Value$376.2K
Trades1
Insiders1
Transaction Details
Dickinson Andrew D
Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-3.00K
Price$125.40
Total Value$376.2K
Shares Owned After171.65K
Transaction DateJun 15, 2026
10b5-1
Footnotes ▸
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
Post-Transaction Holdings
Dickinson Andrew D
| Security | Shares | Change |
|---|---|---|
| Common Stock | 171.65K | -3.00K (-1.72%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-15
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
--- Reporting Owner ---
Name: Dickinson Andrew D
CIK: 0001310204
Role: Officer (Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-15 | Code: S (Open market sale)
Shares: -3,000 | Price: $125.40
Total Value: $376,200.00
Shares Owned After: 171,646 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
--- Footnotes (Complete Index) ---
F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
--- Signature ---
/s/ /s/ Amy Kim by Power of Attorney for Andrew D. Dickinson (2026-06-16)